Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01567020 · ClinicalTrials.gov registry record

Central Auditory Processing Deficits Associated With Blast Exposure

A clinical trial, sponsored by VA Office of Research and Development.

Completed
Registry status
105
Enrollment target

NCT01567020: Completed study, sponsored by VA Office of Research and Development.

NCT01567020 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 105 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01567020 has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
105 participants
Enrollment target

Study Summary

The current conflicts in Afghanistan and Iraq have resulted in unprecedented rates of exposure to high-intensity blasts and resulting brain injury. This research team has established that recently blast-exposed Soldiers show differences from controls on tests of central auditory function. This project will 1) develop a more accurate estimate of the prevalence of central auditory dysfunction among Veterans exposed to blasts over the past ten years, 2) identify the functional outcomes associated with abnormal performance on tests of central processing, and 3) improve understanding of the ways in which blast-exposure resembles and differs from both the normal aging process and non-blast-related TBI in terms of performance on tests of central auditory processing.

Interventions

  • OTHER Diagnostic

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2012-05
Est. Completion 2015-12

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT01567020

The ClinicalTrials.gov registry entry for NCT01567020 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Diagnostic is the first listed.

NCT01567020 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01567020 about?

NCT01567020 is a clinical study titled "Central Auditory Processing Deficits Associated With Blast Exposure". The current conflicts in Afghanistan and Iraq have resulted in unprecedented rates of exposure to high-intensity blasts and resulting brain injury. This research team has established that recently blast-exposed Soldiers show differences from controls on tests of central auditory function. This proje...

What is the current status of trial NCT01567020?

This trial is currently completed. The enrollment target is 105 participants. The study started on 2012-05. Estimated completion is 2015-12.

What interventions are being tested in trial NCT01567020?

The interventions under investigation include: Diagnostic (OTHER).

Who is sponsoring clinical trial NCT01567020?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.